•the Indemnification Agreements, each dated on or around April 15, 2026, by and between the Company and each of its directors and executive officers, the form of which is filed as Exhibit 10.8 to this Current Report on Form 8-K and is incorporated by reference herein.
Descriptions of these agreements are contained in the Prospectus in the section entitled “Certain Relationships and Related Party Transactions” and are incorporated by reference into this Item 1.01. Such descriptions do not purport to be complete and are qualified in their entirety by reference to the full text of each of the agreements attached hereto as Exhibit 4.1, and Exhibits 10.1 to 10.8, which are incorporated by reference into this Item 1.01.
Item 3.02. Unregistered Sales of Equity Securities.
In connection with the consummation of the IPO and on April 15, 2026, the Company sold (i) an aggregate of 44,841,071 shares of Class A Common Stock to Kedge, (ii) an aggregate of 14,311,991 shares of Class A Common Stock to certain unaffiliated institutional investors, (iii) an aggregate of 12,299,462 shares of Class A Common Stock to certain unaffiliated investors and (iv) an aggregate of 10,339,435 shares of Class A Common Stock to certain of the Company’s executive officers, including Jill Wyant, JJ Foley and Jeffrey Krautkramer, and certain other current employees and consultants of the Company, in each case in exchange for LLC units of certain subsidiaries of the Company. Additionally, in connection with the consummation of the IPO, on April 15, 2026, the Company sold 320,676,155 shares of the Company’s Class B common stock, par value $0.0000001 per share (the “Class B Common Stock”), to Holdings in exchange for all of the issued and outstanding shares of capital stock of MIAQ Solutions. The information provided under Item 5.03 of this Current Report on Form 8-K is incorporated by reference into this Item 3.02. The issuances of the Class A Common Stock and Class B Common Stock described in this paragraph were made in reliance on Section 4(a)(2) of the Securities Act, and Rule 506 promulgated thereunder.
Additionally, in connection with the consummation of the IPO, on April 15, 2026, the Company issued 146,556 Equity Appreciation Rights Units (“EAR Units”) to certain former employees and consultants of the Company in respect of, and subject to the same vesting terms as, pre-IPO awards held by such former employees and consultants. The issuances of the EAR Units described in this paragraph were made in reliance on Regulation D under the Securities Act.
Further, in connection with the consummation of the IPO, on April 15, 2026, the Company sold 3,703,704 shares of Class B Common Stock at a price per share equal to the IPO Price to Holdings in a concurrent private placement. The issuance of Class B Common Stock in the concurrent private placement described in this paragraph was made in reliance on Section 4(a)(2) of the Securities Act.
Item 3.03. Material Modification to Rights of Security Holders.
The information provided under Item 5.03 of this Current Report on Form 8-K is incorporated by reference into this Item 3.03.
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On April 15, 2026, Hudson La Force, George Nolen and Jill Wyant were appointed to the Company’s board of directors. Biographical information and other information regarding the committees upon which these directors are expected to serve, related party transactions involving any of these directors, the compensation plans in which such directors participate, and information about any arrangement or understanding between such director and any other persons pursuant to which such director was selected as a director was previously reported in the Prospectus in the sections entitled “Certain Relationships and Related Party Transactions” and “Management” and is incorporated by reference into this Item 5.02.
On or after April 15, 2026, in connection with the IPO, the Company entered into indemnification agreements with each of its directors and executive officers. These agreements provide the Company’s directors and executive officers with contractual rights to indemnification, expense advancement and reimbursement, to the fullest